These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11591143)

  • 41. Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
    Rosales C; Gillard BK; Courtney HS; Blanco-Vaca F; Pownall HJ
    Biochemistry; 2009 Aug; 48(33):8070-6. PubMed ID: 19618959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet.
    Julve J; Escolà-Gil JC; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    Biochim Biophys Acta; 2000 Nov; 1488(3):233-44. PubMed ID: 11082533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The origin and metabolism of a nascent pre-β high density lipoprotein involved in cellular cholesterol efflux.
    Wróblewska M
    Acta Biochim Pol; 2011; 58(3):275-85. PubMed ID: 21750785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
    Cheung MC; Mendez AJ; Wolf AC; Knopp RH
    J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
    Pownall HJ; Hosken BD; Gillard BK; Higgins CL; Lin HY; Massey JB
    Biochemistry; 2007 Jun; 46(25):7449-59. PubMed ID: 17530866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.
    Shachter NS; Ebara T; Ramakrishnan R; Steiner G; Breslow JL; Ginsberg HN; Smith JD
    J Clin Invest; 1996 Aug; 98(3):846-55. PubMed ID: 8698877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
    Ji J; Watts GF; Johnson AG; Chan DC; Ooi EM; Rye KA; Serone AP; Barrett PH
    J Clin Endocrinol Metab; 2006 Mar; 91(3):973-9. PubMed ID: 16368749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.
    Hsu HC; Lee YT; Yeh HT; Chen MF
    J Lab Clin Med; 2001 Jun; 137(6):414-21. PubMed ID: 11385362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.
    Tailleux A; Bouly M; Luc G; Castro G; Caillaud JM; Hennuyer N; Poulain P; Fruchart JC; Duverger N; Fiévet C
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2453-8. PubMed ID: 11073852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opposite effects of plasma from human apolipoprotein A-II transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells.
    Fournier N; Cogny A; Atger V; Pastier D; Goudouneche D; Nicoletti A; Moatti N; Chambaz J; Paul JL; Kalopissis AD
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):638-43. PubMed ID: 11950703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.
    Bar-On H; Roheim PS; Eder HA
    J Clin Invest; 1976 Mar; 57(3):714-21. PubMed ID: 175093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of serum amyloid A on cholesterol esterification in human plasma.
    Steinmetz A; Hocke G; Saïle R; Puchois P; Fruchart JC
    Biochim Biophys Acta; 1989 Nov; 1006(2):173-8. PubMed ID: 2512983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II.
    Rye KA; Garrety KH; Barter PJ
    Biochim Biophys Acta; 1993 Apr; 1167(3):316-25. PubMed ID: 8481394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
    Phillips NR; Havel RJ; Kane JP
    Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ; Breckenridge WC
    Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.